
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation ROE 2011-2026 | NVTA
ROE Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -98.02 | -6.89 | -30.47 | -63.74 | -79.93 | -101.3 | -101.19 | -64.88 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -6.89 | -101.3 | -68.3 |
ROE Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 524.53 | 248.01 | -508.75 | -849.87 | -856.76 | -673.57 | -14.62 | -12.83 | -17.8 | -16.63 | -30.09 | -30.47 | -38.87 | -54.39 | -58.8 | -63.74 | -61.92 | -60.79 | -67.53 | -79.93 | -94.74 | -97.63 | -179.38 | -258.38 | -250.22 | -328.95 | -328.87 | -328.79 | -321.32 | -236.36 | -152.65 | -64.88 | -28.97 | 2.41 | 32.55 | 56.82 | 38.51 | 23.42 | 10.81 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 524.53 | -856.76 | -134.14 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
12.35 | $ 8.93 | 0.62 % | $ 595 M | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 13.54 | -0.81 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 26.01 | 0.68 % | $ 722 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
30.46 | $ 68.14 | 2.71 % | $ 26.6 B | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 153.97 | 1.32 % | $ 7.63 B | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 17.49 | 0.98 % | $ 932 M | ||
|
Guardant Health
GH
|
419.18 | $ 87.81 | 0.72 % | $ 11 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.91 | 0.06 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.53 | 3.88 % | $ 470 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
-205.65 | $ 16.43 | -4.97 % | $ 2.13 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 99.67 | 2.11 % | $ 8.22 B | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 2.87 | 1.06 % | $ 93.1 K | ||
|
IQVIA Holdings
IQV
|
20.91 | $ 167.94 | 1.91 % | $ 28.9 B | ||
|
Danaher Corporation
DHR
|
6.88 | $ 195.04 | 1.91 % | $ 139 B | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 121.88 | 2.18 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 198.1 | -0.43 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
22.45 | $ 113.81 | 1.77 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.13 | 1.69 % | $ 1.44 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 9.28 | 10.24 % | $ 263 M | ||
|
NeoGenomics
NEO
|
-12.91 | $ 8.3 | 0.67 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.2 | 0.93 % | $ 2 B | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 78.55 | 0.06 % | $ 5.3 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.41 | 3.68 % | $ 423 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 453.81 | 0.04 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 213.99 | 1.24 % | $ 25 B | ||
|
Celcuity
CELC
|
-96.68 | $ 113.65 | -1.09 % | $ 4.48 B | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
82.92 | $ 17.53 | 0.75 % | $ 392 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-77.62 | $ 199.0 | 0.67 % | $ 19.6 B | ||
|
OPKO Health
OPK
|
1.03 | $ 1.2 | 0.42 % | $ 833 M |